The Evaluation of Metal Co-ordinating Bis-Thiosemicarbazones as Potential Anti-malarial Agents
Author:
Akladios Fady N.1, Andrew Scott D.1, Boog Samantha J.1, de Kock Carmen2, Haynes Richard K.3, Parkinson Christopher J.1
Affiliation:
1. School of Biomedical Sciences, Charles Sturt University, Orange, NSW 2800, Australia 2. Division of Clinical Pharmacology, University of Cape Town, Groote Schuur Hospital, Observatory 7925, South Africa 3. Centre for Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2531, South Africa
Abstract
Background:The emergence of resistance to the artemisinins which are the current mainstays for antimalarial chemotheraphy has created an environment where the development of new drugs acting in a mechanistally discrete manner is a priority.Objective:The goal of this work was to synthesize ane evaluate bis-thiosemicarbazones as potential antimalarial agents. </P><P> Methods: Fifteen compounds were generated using two condensation protocols and evaluated in vitro against the NF54 (CQ sensitive) strain of Plasmodium falciparum. A preliminary assessment of the potential for human toxicity was conducted in vitro against the MRC5 human lung fibroblast line.Results:The activity of the bis-thiosemicarbazones was highly dependent on the nature of the arene at the core of the structure. The inclusion of a non-coordinating benzene core resulted in inactive compounds, while the inclusion of a pyridyl core resulted in compounds of moderate or potent antimalarial activity (4 compounds showing IC50 < 250 nM).Conclusion:Bis-thiosemicarbazones containing a central pyridyl core display potent antimalarial activity in vitro. Sequestration and activation of ferric iron appears to play a significant role in this activity. Ongoing studies are aimed at further development of this series as potential antimalarials.
Funder
South African MRC Flagship
Publisher
Bentham Science Publishers Ltd.
Reference41 articles.
1. , . World Malaria Report, 2016. World Health Organization: Geneva; Available at: www.who.int, , , 2. Miller LH, Ackerman HC, Su XZ, Wellems TE. Nat Med, Malaria biology and disease pathogenesis: insights for new treatments.,, 2013, 19,, 156-167, 3. Arley F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Khim S, Duru V, Boichier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Menard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Menard D. Nature, A molecular marker of artemisinin-resistant malaria.,, 2014, 505,, 50-55, 4. St Laurent B, Miller B, Burton TA, Amaratunga C, Men S, Sovannaroth S, Fay MP, Miotto O, Gwadz RW, Anderson JM, Fairhurst RM. Nat Commun, Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.,, 2015, 6,, 8614-, 5. Dondorp AM, Fairhurst RM, Slutsker L, MacArthur JR, Bremen JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV. N Engl J Med, The threat of artemisinin-resistant malaria.,, 2011, 365,, 1073-1075,
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|